Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news
Viread Approved for Hepatitis B
|
TUESDAY, Aug. 12 (HealthDay News) -- Viread (tenofovir disoproxil fumarate) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis B infection in adults. The Gilead Sciences drug has been approved since 2001 to treat HIV/AIDS. A serious liver disease, chronic hepatitis B affects about 400 million people globally and some 2 million in the United States, the manufacturer said in a news release. Asian Americans account for nearly half of all cases of the infection, which is a leading cause of liver cancer. A once-daily tablet, Viread blocks an enzyme called HBV DNA polymerase, which is needed by the hepatitis B virus to replicate in liver cells. More information The FDA has more about this drug''s approval history. Last Updated: Aug. 12, 2008 Copyright © 2008 ScoutNews, LLC. All rights reserved. |